[pending] NIACIN (NIACIN)
Pending LLM rewrite. Source: FDA_DRUG D-0584-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
The recalled product
- Product
- NIACIN (NIACIN)
- Brand
- NIACIN
- Manufacturer
- Lannett Company Inc.
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 25282724A
- Exp. Date 2027/01
UPCs (1)
- 0362175320469
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · NIACIN
- HighNiacin Extended-Release Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-11-26
- ModeratePrescription Niacin Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-10-29
- ModeratePrescription Niacin Tablets Recalled for Microbial Contamination
FDA (Drugs) · 2024-01-31
- HighNiacin Extended-Release Tablets Recalled for Manufacturing Microbial Contamination
FDA (Drugs) · 2024-01-31
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27